UCITS
Global and emerging markets exposure through pooled funds
Overview
American Century Investments® currently sub-advises multiple UCITS Funds (Nomura Funds Ireland, plc), advised by Nomura Asset Management U.K. Ltd.
UCITS Funds
Availability, Literature and Daily NAV
American Century Investments sub-advises UCITS Funds (Nomura Funds Ireland, plc), advised by Nomura Asset Management U.K. Ltd. The sub-funds have been authorised for sale in:
Austria
Belgium
Canada
Denmark
Finland
Germany
Iceland
Ireland
Italy
Luxembourg
Netherlands
Norway
Portugal
Singapore
Spain
Sweden
Switzerland
United Kingdom
If you are a resident of one of these countries, access the Fund Documents page to view:
Daily NAV on the UCITS funds,
a listing of the funds available in your country and
multi-lingual versions (if available) of Fact Sheets, Key Investor Information Documents, Prospectus and other relevant documents.
Breakthrough Medical Research
Over 40% of Our Profits Contribute Every Year
Our corporate mission includes making an enduring, meaningful societal impact. Over 40% of our profits go to our controlling owner, the Stowers Institute for Medical Research, a world-class biomedical research organization dedicated to defeating life-threatening diseases.
American Century Emerging Markets Transition Equity Fund (previously named "American Century Emerging Markets Sustainable Impact Equity Fund"). Effective on 28th April 2025, the Sub-Fund has been re-named and re-classified as an Article 8 fund under the Sustainable Finance Disclosure Regulation (EU) 2019/2088 (SFDR). Details of the new strategy can be found in the pre-contractual Annex attached to the Sub-Fund's Supplement.
This fund launched on 2 August 2019, as a result of the merger of the American Century SICAV with Nomura Funds Ireland plc. The launch date refers to the launch date of the original fund.
The EU Sustainable Finance Disclosure Regulation (“SFDR”) requires investment firms to formalise how sustainability is integrated into their business and processes, and to make public and client-facing disclosures on sustainability matters. The aforementioned disclosures relating to Nomura Asset Management U.K. Limited are published on our website at https://www.nomura-asset.co.uk/responsible-investment-asset-management/esg-sustainable-investment/ . Product related disclosures regarding Nomura Funds Ireland PLC and its sub-funds can be found in the prospectus. American Century Emerging Markets Transition Equity Fund is an Art. 8 fund according to SFDR. American Century Concentrated Global Growth Equity Fund is an Art. 8 fund according to SFDR. American Century Emerging Markets Equity Fund is an Art. 8 fund according to SFDR. American Century Global Growth Equity Fund is an Art. 8 fund according to SFDR. American Century Global Small Cap Equity Fund is an Art. 8 fund according to SFDR. American Century U.S. Focused Innovation Equity Fund is an Art. 6 fund according to SFDR.
The funds are sub-funds of Nomura Funds Ireland plc, which is authorised by the Central Bank of Ireland as an open-ended umbrella investment company with variable capital and segregated liability between its sub-funds, established as an undertaking for Collective Investment in Transferable Securities under the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011. The UCITS funds are not intended for distribution to or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. Nomura Asset Management U.K. Ltd. is authorised and regulated by the Financial Conduct Authority.